While the proven Zacks Rank places an emphasis on earnings estimates and estimate revisions to find strong stocks, we also know that investors tend to develop their own individual strategies. With ...

Fintel reports that on May 7, 2026, Wedbush downgraded their outlook for Cross Country Healthcare (NasdaqGS:CCRN) from Outperform to Neutral. Analyst Price Forecast Suggests 17.71% Upside As of April ...

Cross Country Healthcare (CCRN) came out with quarterly earnings of $0.03 per share, missing the Zacks Consensus Estimate of $0.04 per share. This compares to earnings of $0.12 per share a year ago.

Cross Country Healthcare is being acquired by P/E firm Knox Lane for $13.25 per share in an all-cash transaction. Knox Lane has a healthcare staffing business in its portfolio, but the merger involves ...

CCRN is trading near the top of its 52-week range and above its 200-day simple moving average. Price change The price of CCRN shares has held flat since the market last closed. This is a 0.00% change.

Fintel reports that on May 8, 2026, Benchmark downgraded their outlook for Cross Country Healthcare (NasdaqGS:CCRN) from Buy to Hold. Analyst Price Forecast Suggests 9.57% Downside As of April 28, ...

1 Day CCRN 0.00% DJIA 1.14% Russell 2K -0.55% Business/Consumer Services 1.86% ...